<img src="https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2?size=2" nborder="0" align="left" hspace="5" vspace="5" title="sns insider pvt ltd.png" alt="SNS Insider pvt ltd"/>U.S. Market to Hit USD 14.56 Billion and Europe Market to Reach USD 11.46 Billion by 2035 as Self-Administration Devices Gain Momentum.Austin, United States, June 10, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, the <a href="https://www.globenewswire.com/Tracker?data=-cpec1dBh2-xv861UjpQdj119O8C2hQR-2bwTC3xFJKPJGpPjB4JheS-Lltylhbf7TFCQXFQzHpmy_Uv6VDfRbvZF3UiG4hP9e1hslvZ9xFifw9cFiwgE7dPQCQyNZfQrWWWCCMKE-lPampy6bLMJw==" rel="nofollow" target="_blank" title="">Autoinjectors Market</a> was valued at USD 11.04 billion in 2025 and is projected to reach USD 42.76 billion by 2035, expanding at a CAGR of 14.50% during 2026–2035. The global autoinjectors market is also rapidly growing as chronic diseases such as diabetes, rheumatoid arthritis, multiple sclerosis, autoimmune disorders and severe allergies which require prolonged duration of injectable therapy, continue to rise for the long term. Increasing adoption of self-administrable drugs due to growing consumer demand for convenient self-administration, increased treatment adherence, and reduced dependence on healthcare-related infrastructure are driving adoption. The transition towards in-home healthcare and patient-focused treatment along with key innovations including ergonomic designs, connectivity functionalities, concealed needles, and improved safety mechanisms is further contributing market growth. <img alt="Autoinjectors Market" bis_size="{&quot;x&quot;:375,&quot;y&quot;:204,&quot;w&quot;:600,&quot;h&quot;:400,&quot;abs_x&quot;:409,&quot;abs_y&quot;:652}" height="400" src="https://ml.globenewswire.com/Resource/Download/938ba120-0253-4928-8c73-bc48c02b5441/autoinjectors-market-1.jpg" width="600" data-dpi="96" data-filename="Autoinjectors-Market 1.jpg" /> Get a Sample Report of Autoinjectors Market Forecast @ <a href="https://www.globenewswire.com/Tracker?data=-V_r3JYufsrI150cTxAltgYgS-EO3O5YzLxq7SO3URH1EjoG2Sj-46-BEMos2o4C2QN17TG9zcpovGecXLyW1PY3BGoOJ8gqqtmY-B-zcdSaqUM5tMqSpVJbgTE7LQKxWRMw9VA7A5cr_xBYztLqkmkpHc-MgKezLdxFKtAnRZ0=" rel="nofollow" target="_blank" title="">https://www.snsinsider.com/sample-request/3648</a> Rising Chronic Disease Burden Accelerating Market Expansion The autoinjectors market is mainly driven by increasing prevalence of chronic diseases. Increasingly frequent insulin administration and a rising use of biologic therapies are raising the need for self-injectable devices that increase patient independence and compliance, and decrease administration errors. Furthermore, greater awareness regarding early disease management, growing biologics pipelines, increasing healthcare expenditure, and manufacturers' growing focus on patient-friendly drug delivery products continue to support global market growth. Leading Market Players Listed in the Autoinjectors Market Report are: <ul type="disc"><li style="margin-top:0cm; margin-bottom:8pt;">Becton, Dickinson and Company</li><li style="margin-top:0cm; margin-bottom:8pt;">Ypsomed AG</li><li style="margin-top:0cm; margin-bottom:8pt;">Gerresheimer AG</li><li style="margin-top:0cm; margin-bottom:8pt;">Mylan N.V. (Viatris Inc.)</li><li style="margin-top:0cm; margin-bottom:8pt;">Pfizer Inc.</li><li style="margin-top:0cm; margin-bottom:8pt;">Teva Pharmaceutical Industries Ltd.</li><li style="margin-top:0cm; margin-bottom:8pt;">Amgen Inc.</li><li style="margin-top:0cm; margin-bottom:8pt;">Johnson &amp; Johnson</li><li style="margin-top:0cm; margin-bottom:8pt;">Sanofi S.A.</li><li style="margin-top:0cm; margin-bottom:8pt;">Eli Lilly and Company</li><li style="margin-top:0cm; margin-bottom:8pt;">Novartis AG</li><li style="margin-top:0cm; margin-bottom:8pt;">AbbVie Inc.</li><li style="margin-top:0cm; margin-bottom:8pt;">Merck &amp; Co., Inc.</li><li style="margin-top:0cm; margin-bottom:8pt;">Biogen Inc.</li><li style="margin-top:0cm; margin-bottom:8pt;">Owen Mumford Ltd.</li><li style="margin-top:0cm; margin-bottom:8pt;">Haselmeier GmbH</li><li style="margin-top:0cm; margin-bottom:8pt;">West Pharmaceutical Services, Inc.</li><li style="margin-top:0cm; margin-bottom:8pt;">SHL Medical AG</li><li style="margin-top:0cm; margin-bottom:8pt;">Antares Pharma, Inc.</li><li style="margin-top:0cm; margin-bottom:8pt;">Consort Medical plc</li><li style="margin-top:0cm; margin-bottom:8pt;">SHL Group</li><li style="margin-top:0cm; margin-bottom:8pt;">Enable Injections, Inc.</li><li style="margin-top:0cm; margin-bottom:8pt;">Credence MedSystems, Inc.</li><li style="margin-top:0cm; margin-bottom:8pt;">Bespak (Recipharm)</li></ul> Autoinjectors Market Segmentation Analysis: By Type In 2025, disposable autoinjectors held approximately 67.34% revenue share of the world market for autoinjectors and are expected to grow at the highest CAGR of 14.68% over the forecast period. Their increasing adoption is driven by convenience, mitigation of contamination risks, ease of use, and growing adoption in volume-based biologic therapies and emergency care. By Indication Diabetes segment registered the largest market share of approximately 36.21% in 2025 due to rising incidences of diabetes globally and increasing adoption of insulin therapy. The rheumatoid arthritis segment is expected to grow with the fastest CAGR of 15.12% during the analysis period owing to increase in usage of biologic drugs and rise in demand for self-administrated treatment options. By End-Use In 2025, homecare settings accounted for the largest market share of nearly 58.47% and is expected to register the highest CAGR of 15.01% during the forecasting period. Increasing patient preference for self-administration, low healthcare expenditure, and better remote healthcare management further continue pushing the demand in this segment. Regional Insights: In 2025, The revenue share of North America accounted for the highest at around 42.15%. Strong healthcare infrastructure, early adoption of biologics, supportive reimbursement frameworks, and rising prevalence of chronic diseases are some of the factors that should drive market growth over the coming years. Market leadership is also bolstered by the presence of large pharmaceutical and medical device manufacturers. <ul type="disc"><li style="margin-top:0cm; margin-bottom:8pt;">The U.S. Autoinjectors Market was valued at USD 3.85 billion in 2025 and is expected to reach USD 14.56 billion by 2035, expanding at a CAGR of 14.23% during 2026–2035. The increasing utilization of biologics, growing adoption of home healthcare, and rising prevalence of various chronic diseases coupled with continuous advancements in drug delivery technologies are some of the major factors propelling the market.</li></ul> The Europe Autoinjectors market was valued at USD 3.08 billion in 2025 and is projected to reach USD 11.46 billion by 2035 growing at a CAGR of 14.03% in the forecast period of 2026–2035. The prominent factors influencing the market growth are broadening adoption of self-injection therapies, rising healthcare awareness, favorable regulatory support, and increasing demand for advanced drug delivery solutions. Asia Pacific region is projected to be the fastest growing at a CAGR of just over 15.87% during the forecast period. This is due to the rapidly growing patient populations, increasing healthcare expenditure, rising prevalence of diabetes and autoimmune disorders, and improving access to advanced medical technologies in the region. Purchase Single User PDF of Autoinjectors Market Report (20% Discount) @ <a href="https://www.globenewswire.com/Tracker?data=-V_r3JYufsrI150cTxAltgYgS-EO3O5YzLxq7SO3URGDfmwZHSIp6VOwGdIukSjiFGmMCqpy9dzrFokv7NbO4DVBc4YbOwr3Id4baCdae_JkKwDI1D-MYk0TMQG7Mz1qLAflyGY3TMC6r7Auvk4zPw==" rel="nofollow" target="_blank" title="">https://www.snsinsider.com/checkout/3648</a> Recent Developments: <ul type="disc"><li style="margin-top:0cm; margin-bottom:8pt;">February 2025: Ypsomed AG expanded its YpsoMate autoinjector platform capabilities through strategic collaborations with pharmaceutical companies focused on biologic and specialty drug delivery applications.</li><li style="margin-top:0cm; margin-bottom:8pt;">October 2024: SHL Medical introduced enhancements to its Molly autoinjector platform, incorporating advanced usability features designed to improve patient adherence and support large-volume biologic drug administration.</li><li style="margin-top:0cm; margin-bottom:8pt;">2024: West Pharmaceutical Services expanded manufacturing capacity for wearable and self-injection drug delivery technologies to address growing global demand for patient-administered therapies.</li><li style="margin-top:0cm; margin-bottom:8pt;">2024: Gerresheimer AG strengthened partnerships with pharmaceutical companies to support integrated drug-device combination products, including next-generation autoinjector solutions for biologics.</li></ul> Exclusive Sections of the Report (The USPs): <ul type="disc"><li style="margin-top:0cm; margin-bottom:8pt;">PRICING &amp; REIMBURSEMENT ANALYSIS – evaluates pricing structures, reimbursement trends, payer policies, and market access opportunities across major healthcare systems.</li><li style="margin-top:0cm; margin-bottom:8pt;">REGULATORY &amp; COMPLIANCE LANDSCAPE – provides insights into global regulatory frameworks, device approvals, safety standards, and evolving compliance requirements impacting market growth.</li><li style="margin-top:0cm; margin-bottom:8pt;">TECHNOLOGY &amp; INNOVATION BENCHMARKING – assesses advancements in connected devices, smart autoinjectors, needle-safety systems, and user-centric product development trends.</li><li style="margin-top:0cm; margin-bottom:8pt;">MANUFACTURING &amp; SUPPLY CHAIN ANALYSIS – examines production capabilities, component sourcing, contract manufacturing trends, and supply chain efficiencies across the industry.</li><li style="margin-top:0cm; margin-bottom:8pt;">PATIENT ADOPTION &amp; USABILITY INSIGHTS – analyzes patient preferences, adherence patterns, treatment outcomes, and factors influencing acceptance of self-administration devices.</li><li style="margin-top:0cm; margin-bottom:8pt;">COMPETITIVE LANDSCAPE &amp; STRATEGIC POSITIONING – provides detailed assessment of key manufacturers based on product portfolios, partnerships, innovation strategies, geographic presence, and growth initiatives.</li></ul> Autoinjectors Market Report Scope <table align="center" style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; ">Report Attributes</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; ">Details</td></tr><tr><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Market Size in 2025</td><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; ">USD 11.04 Billion</td></tr><tr><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Market Size by 2035</td><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; ">USD 42.76 Billion</td></tr><tr><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">CAGR</td><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; ">CAGR of 14.50% From 2026 to 2035</td></tr><tr><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Base Year</td><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; ">2025</td></tr><tr><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Forecast Period</td><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; ">2026-2035</td></tr><tr><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: top ; ">Historical Data</td><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: top ; ">2022-2024</td></tr><tr><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; ">Key Segments</td><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; ">• By Type [Disposable auto-injectors, Reusable auto-injectors (Prefilled, Empty)] • By Indication [Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies] • By End Use [Homecare Settings, Hospitals &amp; Clinics, Ambulatory Surgical Centers]</td></tr><tr><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; ">Regional Analysis/Coverage</td><td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; ">North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East &amp; Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East &amp; Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).</td></tr></table> Related Market Reports <a href="https://www.globenewswire.com/Tracker?data=6ZF_L-E7XM9_eOMlNdCSu3QtxS5tE3OnQUX7tIWxoYPP7iAF3uYWqPuIE7V_puDFUc7UaQdg0x-fsfSDZY9Fsa0oqN6Bq-f3ILjrxQ3YFYKh-psq8ywFGL8o64g8UmZdin-TzkXM3SCbjzQPxxF6MV7F9SASZ4jBqHLY7WSnyPy3OWz_PcN1Jf9NVME9a-N9" rel="nofollow" target="_blank" title="Self-injection Devices Market Size 2026">Self-injection Devices Market Size 2026</a> <a href="https://www.globenewswire.com/Tracker?data=d_qt7KbLDll1LzUj5q0NI0fzweBycuq7qVFhp1G60w2dHGt6oOdZG7vxTpctJedSL8sWanci-KnHOp2TxkCD-PTuNQQDZ3bRo0HqTFSkcbnQ7i0gtjk917PYAwlE-BPSFyf7UyHpcYNCmmMrSX8eQHaaIe6x70VZnHAL2SUHnAU=" rel="nofollow" target="_blank" title="Injection Pen Market Share 2026">Injection Pen Market Share 2026</a> <a href="https://www.globenewswire.com/Tracker?data=pjY41AAILElf3PBUuQaZ4CWBR1cpXj0VFm_F04RjlcISdnU89-bqjX8mh4RIl1KhhKJUCSglbIANCXsmzyUnpWt5yX9n33hJFA0HsxxCU8rhSwdtaDPtLrICnizsoUCoU_vDy0Wq8XzFJTAP5eXWxd7MNGAgKSoPgHSj6GoB_lI=" rel="nofollow" target="_blank" title="Pen Needles Market Growth 2026">Pen Needles Market Growth 2026</a> <a href="https://www.globenewswire.com/Tracker?data=MXY4QCOP5v8AdonM3r7miKKOr3IZc84CYv0L78nf3Cs9ykIt0jUo3UcgTSyzJ7NfoK738INxFi_yn_2FZodu7PBCdsCvVwp3U0dQetwJa8PSa-m98bMJIJ5LRw0T9kPZYW9-0oE2ZUDDi17TK6G8nzLG_RnzI9fjdyl4MdTUNrU7jUhodKg-imOH6qHBKUYw" rel="nofollow" target="_blank" title="Smart Insulin Pens Market Trends 2026">Smart Insulin Pens Market Trends 2026</a> <a href="https://www.globenewswire.com/Tracker?data=c2BEsVLPJpzv1lwxjrr_HJDVzzyLMo-m-tCFBgb-8Gy3njhNnmIRj2UK6YvAbyPuHfI9gkVdubE9HQUZCdYT3eAkdSVZps_yDl0oxHzHFikmyn-QR5aEMd_R3CJGxJCrGrV_qZd_H4jFm94xPMoFrdaYtgqaIpqmVYSTuLd6RxfYco-M26otUIqYggD-4oko" rel="nofollow" target="_blank" title="Drug Delivery Devices Market Outlook 2026">Drug Delivery Devices Market Outlook 2026</a> About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. <pre>CONTACT: Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315-961-9094 (US)
Email: info@snsinsider.com
</pre> <img alt="" src='https://ml.globenewswire.com/media/OTYzYWY0NDYtMDcwZS00NTkwLThjMWUtMGYxYWFmNjlmN2Q3LTEyNjg4MTktMjAyNi0wNi0xMC1lbg==/tiny/SNS-Insider-pvt-ltd.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Autoinjectors Market to Value USD 42.76 Billion by 2035, Registering a CAGR of 14.50% – SNS Insider

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn